Randomized clinical trial of open-cell vs. closed-cell stents for carotid stenting and effects of stent design on cerebral embolization. J Vasc Surg 2011; 54: 1310-1316.
Published: 5th March 2012
Authors: Timaran CH, Rosero EB, Higuera A, Ilarraza A, Modrall JG, Clagett PG et al.
This trial included 40 procedures. The rate of perioperative cerebral embolization was monitored using transcranial Doppler and postoperative MRI. There were no differences in the rates of embolization on either assessment between open or covered stents. One patient in the series had a minor perioperative stroke.Pubmed Link
You may also be interested in
A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg 2018; 68: 1744-1752.
Authors: Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B et al.
Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 2019; 380: 1305-1315.
Authors: Arabi YM, Al-Hameed F, Burns KEA, Mehta S, Alsolamy SJ, Alshahrani MS et al.
A randomized trial of class 2 and class 3 elastic compression in the prevention of recurrence of venous ulceration. J Vacs Surg Venous Lymphat Disord 2018; 6: 717–723.
Authors: Milic DJ, Zivic SS, Bogdanovic DC, Golubovic MD, Lazarevic MV, Lazarevic KK et al.
A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy. J Vasc Surg 2018; 68: 1241–1256.
Authors: Texakalidis P, Giannopoulos S, Charisis N, Giannopoulos S, Karasavvidis T, Koullias G et al.
Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vas Venous Lymphatic Disorders 2018; 6: 606–613.
Authors: Gibson K, Morrison N, Kolluri R, Vasquez M, Weiss R, Cher D et al.
Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials. Surgery 2018; 164: 1234-1240.
Authors: Rausa E, Kelly ME, Asti E, Aiolfi A, Bonitta G, Winter DC et al.
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N Engl J Med 2019; 380: 720-728.
Authors: Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T et al.
Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med 2019; 380: 711-719.
Authors: Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A et al.
A randomized clinical trial of buffered tumescent local anaesthesia during endothermal ablation for superficial venous incompetence. Eur J Vasc Endovasc Surg 2018; 56: 699-708.
Authors: Nandhra S, Wallace T, El-Sheikha J, Leun C, Carradice D, Chetter I et al.
Management of extremity fasciotomy sites prospective randomized evaluation of two techniques. Am J Surg 2018; 216: 736–739.
Authors: Johnson LS, Chaar M, Ball CG, Perez S, Nicholas JM, Wyrzykowski AD et al.
Thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma. The PROTECTOR randomized clinical trial. JAMA Surg 2018; 153: 939-946.
Authors: Jung YJ, Seo HS, Park CH, Jeon HM, Kim J-I, Yim HW et al.
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high-risk transient ischaemic attack. BMJ 2018; 363: k5108.
Authors: Hao Q, Tampi M, O’Donnell M, Foroutan F, Siemieniuk RAC, Guyatt G et al.